Skip to main content
. 2023 Apr 24;14:1143548. doi: 10.3389/fimmu.2023.1143548

Table 4.

Subgroup analysis of fecal zonulin.

Subgroup by Studies Participants MD (95% CI) I2 P P for heterogeneity
Country Austria 3 112 -1.57[-17.76, 14.62] 72% 0.85 0.03
Netherlands 2 78 -1.19[-26.96, 24.58] 0% 0.93 0.34
Population characteristics Endurance trained men 1 23 -9.40 [-18.17, -0.62] NA 0.04 NA
Patients 4 167 6.48 [-2.74, 15.70] 0% 0.17 0.57
Duration of treatment < 6 months 4 110 -8.69 [-16.99, -0.40] 0% 0.04 0.65
≥6 months 1 80 7.89 [-2.00, 17.78] NA 0.12 NA